NasdaqGS - Nasdaq Real Time Price USD

Precigen, Inc. (PGEN)

Compare

1.1750

-0.0050

(-0.42%)

At close: January 10 at 4:00:01 PM EST

1.1899

+0.01

+(1.27%)

After hours: 7:56:25 PM EST

Currency in USD All numbers in thousands

Download

Breakdown

TTM

12/31/2023

12/31/2022

12/31/2021

12/31/2020

Total Revenue

3,963.0000

6,225.0000

26,909.0000

14,267.0000

103,178.0000

Cost of Revenue

4,456.0000

6,119.0000

6,339.0000

5,745.0000

55,513.0000

Gross Profit

-493.0000

106.0000

20,570.0000

8,522.0000

47,665.0000

Operating Expense

94,864.0000

89,029.0000

95,176.0000

99,927.0000

133,348.0000

Operating Income

-95,357.0000

-88,923.0000

-74,606.0000

-91,405.0000

-85,683.0000

Net Non Operating Interest Income Expense

2,118.0000

2,769.0000

-6,641.0000

-18,584.0000

-15,949.0000

Other Income Expense

-48,363.0000

-10,208.0000

1,281.0000

-978.0000

-2,223.0000

Pretax Income

-141,602.0000

-96,362.0000

-79,966.0000

-110,967.0000

-103,855.0000

Tax Provision

-2,038.0000

-458.0000

-189.0000

-160.0000

-82.0000

Net Income Common Stockholders

-139,564.0000

-95,904.0000

28,317.0000

-92,166.0000

-170,521.0000

Diluted NI Available to Com Stockholders

-139,564.0000

-95,904.0000

28,317.0000

-92,166.0000

-170,521.0000

Basic EPS

-0.54

-0.39

0.14

-0.47

-1.02

Diluted EPS

-0.54

-0.39

0.14

-0.47

-1.02

Basic Average Shares

256,670.8560

244,536.2210

200,360.8210

197,759.9000

167,065.5390

Diluted Average Shares

256,670.8560

244,536.2210

200,360.8210

197,759.9000

167,065.5390

Total Operating Income as Reported

-140,737.0000

-99,758.0000

-75,726.0000

-91,948.0000

-86,603.0000

Total Expenses

99,320.0000

95,148.0000

101,515.0000

105,672.0000

188,861.0000

Net Income from Continuing & Discontinued Operation

-139,564.0000

-95,904.0000

28,317.0000

-92,166.0000

-170,521.0000

Normalized Income

-94,837.1295

-85,120.4978

-78,659.6471

-110,264.7829

-102,853.7264

Interest Income

2,131.0000

3,237.0000

133.0000

171.0000

2,451.0000

Interest Expense

13.0000

468.0000

6,774.0000

18,755.0000

18,400.0000

Net Interest Income

2,118.0000

2,769.0000

-6,641.0000

-18,584.0000

-15,949.0000

EBIT

-141,589.0000

-95,894.0000

-73,192.0000

-92,212.0000

-85,455.0000

EBITDA

-136,110.0000

-89,226.0000

-62,427.0000

-78,451.0000

-67,939.0000

Reconciled Cost of Revenue

4,456.0000

6,119.0000

6,339.0000

5,745.0000

55,513.0000

Reconciled Depreciation

5,479.0000

6,668.0000

10,765.0000

13,761.0000

17,516.0000

Net Income from Continuing Operation Net Minority Interest

-139,564.0000

-95,904.0000

-79,777.0000

-110,807.0000

-103,773.0000

Total Unusual Items Excluding Goodwill

-45,380.0000

-10,835.0000

-1,120.0000

-543.0000

-920.0000

Total Unusual Items

-45,380.0000

-10,835.0000

-1,120.0000

-543.0000

-920.0000

Normalized EBITDA

-90,730.0000

-78,391.0000

-61,307.0000

-77,908.0000

-67,019.0000

Tax Rate for Calcs

0.0000

Tax Effect of Unusual Items

-653.1295

-51.4978

-2.6471

-0.7829

-0.7264

12/31/2020 - 8/8/2013

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

VOR Vor Biopharma Inc.

1.5550

-4.60%

ATAI Atai Life Sciences N.V.

1.5000

-7.41%

HALO Halozyme Therapeutics, Inc.

52.80

-1.79%

CTMX CytomX Therapeutics, Inc.

0.8801

-10.45%

ELEV Elevation Oncology, Inc.

0.6504

-13.72%

NUVB Nuvation Bio Inc.

2.7800

-7.64%

SGMO Sangamo Therapeutics, Inc.

1.1650

-4.12%

ALXO ALX Oncology Holdings Inc.

1.7700

-4.32%

GOSS Gossamer Bio, Inc.

0.9721

-7.42%

FGEN FibroGen, Inc.

0.6160

-5.35%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Precigen, Inc. (PGEN)

Upgrade to begin using 40 years of financial statements and get so much more.

Related Tickers